CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	6 Months Ended		64 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (463,651)	$ (488,104)	$ (5,355,758)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	16,249	16,249	151,665
Allowance for uncollectible notes receivable		13,867	38,867
Amortization of deferred finance costs	40,402	1,252	73,894
Interest (income) expense on fair value adjustments of convertible notes payable	7,721	(18,279)	255,650
Interest accrued on note receivable			(11,705)
Write-off of uncollectible deposit			20,000
Loss on extinguishment of related party debt	31,398		375,314
Loss on impairment		21,000	21,000
Stock issued for services	76,885	72,651	1,825,412
Stock issued for finance fees			3,500
Changes in operating assets and liabilities:
Prepaid expenses			(43,863)
Deposits and other receivables		(44,084)	(23,345)
Accounts payable and accrued liabilities	12,658	127,910	257,325
Net cash used in operating activities	(278,338)	(297,538)	(2,412,044)
CASH FLOWS FROM INVESTING ACTIVITIES
Net proceeds from notes receivable			(25,000)
Purchase of securities	(12,000)	(22,100)	(34,100)
Acquisition of equipment			(325,000)
Net cash provided by (used in) investing activities	(12,000)	(22,100)	(384,100)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from the issuance of common stock	139,000	178,670	1,928,144
Proceeds from the issuance of convertible notes, related parties	50,000		56,000
Proceeds from the issuance of convertible notes, non related parties	72,500	20,000	585,800
Proceeds from the issuance of notes payable	30,000	155,000	306,500
Proceeds from the issuance of notes payable, related parties		5,000	6,000
Payments on convertible notes payable		(25,000)	(25,000)
Payments on notes payable	(10,000)		(65,000)
Payments on notes payable - related parties			(1,000)
Proceeds on loans from stockholders			35,925
Payments on loans from stockholders		(5,225)	(31,225)
Net cash provided by financing activities	281,500	328,445	2,796,144
NET INCREASE IN CASH	(8,838)	9,907
CASH, BEGINNING OF PERIOD	8,838	3,071
CASH, END OF PERIOD		12,978
NONCASH FINANCING ACTIVITIES:
Due to Organetix, Inc. reclassified to additional paid-in capital			91,500
Common stock issued for loan financing fees	1,500	5,000	7,750
Common stock issued to satisfy minimum value guarantee			87,667
Convertible debt converted to common stock including accrued interest	91,259	182,212	1,069,521
Common stock issued to satisfy debt	70,851		70,851
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest			$ 3,660